Clinical responsiveness of glioblastoma multiforme to chemotherapy after vaccination
/in Dendritic Cells, Glioblastoma, International Publications /von 2004-08-15 / Clin. Cancer Res. 2004 Aug;10(16):5316-26Therapeutic cancer vaccines: using unique antigens
/in Dendritic Cells, Hyperthermia, International Publications /von 2004-08-05 / Proc. Natl. Acad. Sci. U.S.A. 2004 Oct;101 Suppl 2:14653-6High cell surface expression of Newcastle disease virus proteins via replicon vectors demonstrates syncytia forming activity of F and fusion promotion activity of HN molecules
/in International Publications, Newcastle Disease Virus /von 2004-08-01 / Int. J. Oncol. 2004 Aug;25(2):293-302[Antitumor research on mouse melanoma with combined application of Newcastle disease virus and its HN gene]
/in International Publications, Malignant Melanoma /von 2004-08-01 / Ai Zheng 2004 Aug;23(8):910-3Prospects for dendritic cell vaccination in persistent infection with hepatitis C virus
/in Chronic Virus Hepatitis, International Publications /von 2004-08-01 / J. Clin. Virol. 2004 Aug;30(4):283-90Production and efficacy of a dendritic cell-based therapeutic vaccine for murine chronic hepatitis B virus carrierer
/in Chronic Virus Hepatitis, International Publications /von 2004-08-01 / Int. J. Mol. Med. 2004 Aug;14(2):295-9
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
- Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum
- Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution